Product Code: 27068
KEY FINDINGS
The global medical simulation market is estimated to project a CAGR of 12.07% during the forecast period. The increasing safety concerns for patients, rising benefits for medical professionals with regards to simulators, and rising demand for simulation in minimally invasive surgery (MIS), are the factors propelling market growth.
MARKET INSIGHTS
The web-based simulation IS the fastest growing service, and the major end-users are the hospitals and clinics. The technological advancements and the increased applications of technology-enhanced simulation, along with rising demand for medical simulation in emerging countries, are estimated to result in growth opportunities for the market. However, the complexity in the integration of medical simulation into traditional healthcare education programs, and resulting operational challenges, may hinder the market growth. The lack of absolute reality in simulations set up is another factor that poses a threat to market growth.
REGIONAL INSIGHTS
On a geographical basis, the global medical simulation market is assessed on the basis of markets across the regions, such as North America, Europe, Asia Pacific, and Rest of World. North America had the largest market share in the global market. This can be attributed to the factor that the U.S is the leader in the market, and has the benefits of market approval, and exposure to new services. The Asia Pacific region is expected to be the fastest-growing region during the forecast period.
COMPETITIVE INSIGHTS
The major companies operating in the market are, Nasco, Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Mentice AB, Gaumard Scientific Company, KindHeart Inc., Canadian Aviation Electronics (Cae), Limbs & Things Ltd., etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of contents
1. RESEARCH SCOPE
- 1.1. STUDY GOALS
- 1.2. SCOPE OF THE MARKET STUDY
- 1.3. WHO WILL FIND THIS REPORT USEFUL?
- 1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
- 2.1. SOURCES OF DATA
- 2.1.1. SECONDARY DATA
- 2.1.2. PRIMARY DATA
- 2.2. TOP-DOWN APPROACH
- 2.3. BOTTOM-UP APPROACH
- 2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
- 3.1. MARKET SUMMARY
- 3.2. KEY FINDINGS
- 3.2.1. WEB-BASED SIMULATION IS THE FASTEST GROWING PRODUCT & SERVICE
- 3.2.2. LOW-FIDELITY CONSTITUTES THE HIGHEST MARKET SHARE IN TERMS OF FIDELITY
- 3.2.3. HOSPITALS AND CLINICS ARE THE WIDELY USED MEDICAL SIMULATOR END USER
4. MARKET DETERMINANTS
- 4.1. MARKET SCOPE & DEFINITION
- 4.2. MARKET DRIVERS
- 4.2.1. RAPIDLY RISING PATIENT SAFETY CONCERN
- 4.2.2. INCREASING BENEFITS OF USING SIMULATORS BY MEDICAL PROFESSIONALS
- 4.2.3. DEMAND OF MEDICAL SIMULATION IN MINIMALLY INVASIVE SURGERY (MIS)
- 4.3. MARKET RESTRAINTS
- 4.3.1. HIGH COST OF MEDICAL SIMULATORS
- 4.3.2. LACK OF SKILLED PROFESSIONALS
- 4.3.3. LACK OF FUNDING COUPLED WITH CHANGING REGULATORY SCENARIO
- 4.4. MARKET OPPORTUNITIES
- 4.4.1. TECHNOLOGICAL ADVANCEMENTS
- 4.4.2. DEMAND FOR MEDICAL SIMULATION IN EMERGING COUNTRIES
- 4.5. MARKET CHALLENGES
- 4.5.1. CHALLENGES IN THE INTEGRATION OF MEDICAL SIMULATION
- 4.5.2. LACK OF REALITY IN SIMULATIONS SETUPS
5. MARKET BY PRODUCTS & SERVICE
- 5.1. MODEL-BASED SIMULATION
- 5.1.1. PATIENT SIMULATION
- 5.1.1.1. TASK TRAINER SIMULATION
- 5.1.1.2. MANIKIN-BASED SIMULATION
- 5.1.1.3. STANDARDIZED PATIENT SIMULATION
- 5.1.2. SURGICAL SIMULATION
- 5.1.2.1. LAPAROSCOPIC SURGICAL SIMULATORS
- 5.1.2.2. ARTHROSCOPIC SURGICAL SIMULATORS
- 5.1.2.3. CARDIOVASCULAR SIMULATORS
- 5.1.2.4. GYNECOLOGY SIMULATORS
- 5.1.2.5. OTHER SURGICAL SIMULATION
- 5.2. WEB-BASED SIMULATION
- 5.2.1. SIMULATION SOFTWARE
- 5.2.2. PERFORMANCE RECORDING SOFTWARE
- 5.2.3. VIRTUAL TUTORS
- 5.3. SIMULATION TRAINING SERVICES
6. MARKET BY FIDELITY
- 6.1. LOW-FIDELITY
- 6.2. MEDIUM-FIDELITY
- 6.3. HIGH-FIDELITY
7. MARKET BY END-USER
- 7.1. ACADEMIC INSTITUTIONS & RESEARCH CENTERS
- 7.2. HOSPITALS & CLINICS
- 7.3. MILITARY ORGANIZATIONS
8. KEY ANALYTICS
- 8.1. PORTER'S FIVE FORCES MODEL
- 8.1.1. THREAT OF NEW ENTRANTS
- 8.1.2. THREAT OF SUBSTITUTE
- 8.1.3. BARGAINING POWER OF BUYERS
- 8.1.4. BARGAINING POWER OF SUPPLIERS
- 8.1.5. THREAT OF COMPETITIVE RIVALRY
- 8.2. MEDICAL SIMULATION MARKET TRENDS
- 8.3. REGULATORY FRAMEWORK
- 8.3.1. REGULATIONS IN NORTH AMERICA
- 8.3.2. REGULATIONS IN EUROPE
- 8.3.3. REGULATIONS IN ASIA PACIFIC
- 8.4. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
- 9.1. NORTH AMERICA
- 9.1.1. THE UNITED STATES
- 9.1.2. CANADA
- 9.2. EUROPE
- 9.2.1. GERMANY
- 9.2.2. FRANCE
- 9.2.3. THE UNITED KINGDOM
- 9.2.4. ITALY
- 9.2.5. SPAIN
- 9.2.6. REST OF EUROPE
- 9.3. ASIA PACIFIC
- 9.3.1. JAPAN
- 9.3.2. CHINA
- 9.3.3. INDIA
- 9.3.4. AUSTRALIA
- 9.3.5. SOUTH KOREA
- 9.3.6. REST OF ASIA PACIFIC
- 9.4. REST OF WORLD
- 9.4.1. LATIN AMERICA
- 9.4.2. MIDDLE EAST AND AFRICA
10. COMPETITIVE LANDSCAPE
- 10.1. MARKET SHARE ANALYSIS
- 10.2. COMPANY PROFILES
- 10.2.1. 3D SYSTEMS CORPORATION
- 10.2.2. CANADIAN AVIATION ELECTRONICS (CAE)
- 10.2.3. GAUMARD SCIENTIFIC COMPANY
- 10.2.4. KYOTO KAGAKU CO. LTD
- 10.2.5. KINDHEART INC.
- 10.2.6. LAERDAL MEDICAL AS
- 10.2.7. LIMBS & THINGS LTD.
- 10.2.8. MENTICE AB
- 10.2.9. NASCO
- 10.2.10. SIMULAB CORPORATION
- 10.2.11. SIMULAIDS INC.
- 10.2.12. SURGICAL SCIENCE SWEDEN AB
